Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780) - Unité de Spectrométrie de Masse Biologique et Protéomique
Article Dans Une Revue Redox Biology Année : 2022

Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780)

Salvatore Rizza
  • Fonction : Auteur

Résumé

The effects of Auranofin (AF) on protein expression and protein oxidation in A2780 cancer cells were investigated through a strategy based on simultaneous expression proteomics and redox proteomics determinations. Bioinformatics analysis of the proteomics data supports the view that the most critical cellular changes elicited by AF treatment consist of thioredoxin reductase inhibition, alteration of the cell redox state, impairment of the mitochondrial functions, metabolic changes associated with conversion to a glycolytic phenotype, induction of ER stress. The occurrence of the above cellular changes was extensively validated by performing direct biochemical assays. Our data are consistent with the concept that AF produces its effects through a multitarget mechanism that mainly affects the redox metabolism and the mitochondrial functions and results into severe ER stress. Results are discussed in the context of the current mechanistic knowledge existing on AF.
Fichier principal
Vignette du fichier
1-s2.0-S2213231722000660-main.pdf (6.33 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03616465 , version 1 (22-03-2022)

Identifiants

Citer

Giovanni Chiappetta, Tania Gamberi, Fiorella Faienza, Xhesika Limaj, Salvatore Rizza, et al.. Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780). Redox Biology, 2022, 52, pp.102294. ⟨10.1016/j.redox.2022.102294⟩. ⟨hal-03616465⟩
122 Consultations
34 Téléchargements

Altmetric

Partager

More